Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome. Academic Article uri icon

start page

  • 662

end page

  • 665

abstract

  • The link between cyclobenzaprine (Flexeril) administration and serotonin syndrome (SS) is subject to debate. Establishing such a connection is difficult because of the limited number of case reports available and the almost complete ignorance of its preclinical pharmacology. In this context, evidence is provided here that cyclobenzaprine blocks the serotonin and norepinephrine transporters and binds to another set of five serotonin receptors. SS should be considered when indicative signs occur in the context of cyclobenzaprine use.

date/time value

  • 2011

Digital Object Identifier (DOI)

  • 10.1038/clpt.2011.177

PubMed Identifier

  • 21975349

volume

  • 90

number

  • 5

keywords

  • Amitriptyline
  • Antidepressive Agents, Tricyclic
  • Humans
  • Norepinephrine Plasma Membrane Transport Proteins
  • Protein Binding
  • Receptors, Serotonin
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Syndrome